Partner at Extera Partners, CEO of Janus Biotherapeutics, SVP of Corporate Development BioAssets, M&A Team, Millennium Pharmaceutical, Consultant, Booz Allen, MBA Harvard Business School, MS, Stanford
Founder, Extera Partners, Head Life Science Armory Securities, Board Members at Janus Biotherapeutics and Acer Biopharmaceuticals
Dr. Dove has extensive experience in healthcare and leading development stage life science companies. Previously, Dr. Dove was President and CEO of Aeris Therapeutics, which developed and commercialized a treatment for patients with advanced emphysema. Dr. Dove also served as President and CEO of Celadon Science, a biotechnology company focused on skin and wound healing, and as President and CEO of TEI Biosciences, a regenerative medicine company. Dr. Dove received an M.D. degree from New York University and an MBA from the Haas School of Business at Berkeley and a BA in Cell Biology from Middlebury College.